Cointime

Gate2Brain

company

About

Gate2Brain is a biotech company to improve drug delivery with peptide-based patented technology.

  • 1 - 10

Highlights

Total Funding Amount
€2.50M
Funding Rounds
1
Investors
1
Investments
2

Details

Last Funding Type
Grant
Last Funding Money Raised
€2.50M
Industries
Biotechnology,Medical
Number Of Employee
1 - 10
Operating Status
Active

Gate2Brain is an early-stage biotech company launched to improve drug delivery across biological barriers through the use of a radically innovative peptide-based patented technology. Its technology aims to transport drugs to the brain, increasing the efficiency and reducing the side effects of treatments for brain diseases.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
€2.50M
Gate2Brain has raised a total of €2.50M in funding over 2 rounds. Their latest funding was raised on Dec 19, 2022 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 19, 2022 Grant €2.50M 1 European Innovation Council — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Gate2Brain has made 2 investments. Their most recent investment was on Dec 4, 2020, when FiscalNote raised $160M.
Date Company Name
Round Money Raised Industry Lead Investor
Dec 4, 2020 FiscalNote
Series Unknown $160M Artificial Intelligence —
Dec 4, 2020 FiscalNote
Debt Financing — Artificial Intelligence —

Investors

Number of Lead Investors
Number of Investors
1
1
Gate2Brain is funded by 1 investors. European Innovation Council are the most recent investors.
Investor Name Lead Investor Funding Round
European Innovation Council Yes Grant
Cointime
เนื้อหา
บริษัท